{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T11:22:37Z","timestamp":1781176957918,"version":"3.54.1"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"43","license":[{"start":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T00:00:00Z","timestamp":1729814400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"2024 Yichang Medical and Health Research Project","award":["A24-2-025"],"award-info":[{"award-number":["A24-2-025"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10,25]]},"abstract":"<jats:p>This study aimed to explore the organ-protective effects of dexmedetomidine in patients with sepsis combined with myocardial injury. From December 2021 to December 2023, 263 sepsis patients with myocardial injury were included based on inclusion and exclusion criteria. They were divided into an experimental group (n\u2005=\u2005122), who had previously received dexmedetomidine, and a control group (n\u2005=\u2005141), who had received midazolam. After matching baseline characteristics, the treatment outcomes between the 2 groups were compared. In a propensity score-matched cohort of 263 patients, each group had 62 individuals with balanced baseline characteristics. The experimental group showed significantly lower heart rates on days 1, 3, and 7 compared to the control (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.05). Biomarkers high-sensitivity troponin I and creatine kinase-MB decreased significantly by days 3 and 7, with lower levels in the experimental group. B-type natriuretic peptide levels were also lower in the experimental group on days 3 and 7. Heart function improved in both groups, with the experimental group showing better outcomes. Inflammatory markers decreased significantly after 7 days, with the experimental group having lower levels. Hospitalization duration was similar between groups. Dexmedetomidine reduces heart rate and inflammatory markers, protects myocardial cells, and improves cardiac function in patients with sepsis and myocardial injury. It shows potential as a treatment option, with future research needed to assess its long-term efficacy and safety.<\/jats:p>","DOI":"10.1097\/md.0000000000040257","type":"journal-article","created":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T15:05:28Z","timestamp":1730214328000},"page":"e40257","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Clinical effects of dexmedetomidine on patients with sepsis and myocardial injury"],"prefix":"10.1097","volume":"103","author":[{"given":"Xiaomin","family":"Si","sequence":"first","affiliation":[{"name":"Department of Cardiopulmonary Rehabilitation Center, Shiyan Taihe Hospital Affiliated to Hubei Medical College, Shiyan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonglue","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Guangzhou Xinshi Hospital, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9610-4456","authenticated-orcid":false,"given":"Zhanqun","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The First College of Clinical Medical Science, China Three Gorges University, Yichang Central People\u2019s Hospital, Yichang, Hubei, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMra021333","article-title":"The pathophysiology and treatment of sepsis.","volume":"348","author":"Hotchkiss","year":"2003","journal-title":"N Engl J Med"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.chest.2018.08.1037","article-title":"The septic heart: current understanding of molecular mechanisms and clinical implications.","volume":"155","author":"Martin","year":"2019","journal-title":"Chest"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1186\/s13054-019-2690-4","article-title":"The effect of dexmedetomidine and clonidine on the inflammatory response in critical illness: a systematic review of animal and human studies.","volume":"23","author":"Flanders","year":"2019","journal-title":"Crit care"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3389\/fimmu.2019.00225","article-title":"Proteasome dependent actin remodeling facilitates antigen extraction at the immune synapse of B cells.","volume":"10","author":"Iba\u00f1ez Vega","year":"2019","journal-title":"Front Immunol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.3389\/fimmu.2018.02724","article-title":"IL-17C Mitigates murine acute graft-vs.-host disease by promoting intestinal barrier functions and treg differentiation.","volume":"9","author":"Gong","year":"2018","journal-title":"Front Immunol"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13613-023-01235-5","article-title":"Association between left ventricular systolic function parameters and myocardial injury, organ failure and mortality in patients with septic shock.","volume":"14","author":"Blixt","year":"2024","journal-title":"Ann Intensive Care"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"4710","DOI":"10.3390\/ijms25094710","article-title":"Current perspectives of mitochondria in sepsis-induced cardiomyopathy.","volume":"25","author":"Kuroshima","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1007\/s00431-023-05236-1","article-title":"The effect of myocardial dysfunction on mortality in children with septic shock: a prospective observational study.","volume":"182","author":"Soydan","year":"2023","journal-title":"Eur J Pediatr"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"1334759","DOI":"10.3389\/fcvm.2024.1334759","article-title":"Prognostic value of right ventricular free wall strain in patients with sepsis.","volume":"11","author":"Chen","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s13054-022-04095-w","article-title":"Feasibility and discriminatory value of tissue motion annular displacement in sepsis-induced cardiomyopathy: a single-center retrospective observational study.","volume":"26","author":"Song","year":"2022","journal-title":"Crit Care"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"1200441","DOI":"10.3389\/fcvm.2023.1200441","article-title":"Sepsis-induced myocardial dysfunction: heterogeneity of functional effects and clinical significance.","volume":"10","author":"Shvilkina","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"R13-20250504","first-page":"147","article-title":"Recent insights into the pathogenesis of bacterial sepsis.","volume":"68","author":"Anas","year":"2010","journal-title":"Neth J Med"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1939-1676.2012.00905.x","article-title":"The immunopathology of sepsis: pathogen recognition, systemic inflammation, the compensatory anti-inflammatory response, and regulatory T cells.","volume":"26","author":"Lewis","year":"2012","journal-title":"J Vet Intern Med"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/MEJ.0000000000000437","article-title":"Lactate-arterial and venous agreement in sepsis: a prospective observational study.","volume":"25","author":"Datta","year":"2018","journal-title":"Eur J Emerg Med"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jcrc.2014.03.028","article-title":"Myocardial depression in sepsis: from pathogenesis to clinical manifestations and treatment.","volume":"29","author":"Antonucci","year":"2014","journal-title":"J Crit Care"},{"key":"R17-20250504","first-page":"1","article-title":"Involvement of mitochondrial disorders in septic cardiomyopathy.","volume":"2017","author":"Arthur","year":"2017","journal-title":"Oxid Med Cell Longevity"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"3423450","DOI":"10.1155\/2016\/3423450","article-title":"Oxidative nitrosative stress and myocardial dysfunctions in sepsis: evidence from the literature and postmortem observations.","volume":"2016","author":"Neri","year":"2016","journal-title":"Mediators Inflamm"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40560-016-0148-1","article-title":"Sepsis-induced myocardial dysfunction: pathophysiology and management.","volume":"4","author":"Kakihana","year":"2016","journal-title":"J Intensive Care"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1152\/ajpheart.00887.2012","article-title":"Reduction of cardiomyocyte S-nitrosylation by S-nitrosoglutathione reductase protects against sepsis-induced myocardial depression.","volume":"304","author":"Sips","year":"2013","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/SHK.0000000000000261","article-title":"Dysregulation of intracellular calcium transporters in animal models of sepsis induced cardiomyopathy.","volume":"43","author":"Hobai","year":"2015","journal-title":"Shock"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.pharmthera.2010.11.001","article-title":"Endothelium-derived vasoactive agents, AT1 receptors and inflammation.","volume":"131","author":"Mackenzie","year":"2011","journal-title":"Pharmacol Ther"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1177\/1751143718765407","article-title":"Immune therapy in sepsis: are we ready to try again?","volume":"19","author":"Davies","year":"2018","journal-title":"J Intensive Care Soc"},{"key":"R24-20250504","first-page":"95","article-title":"Immunologic dissonance and its clinical significance in sepsis.","volume":"42","author":"Wu","year":"2017","journal-title":"Med J Chin PLA"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12871-018-0621-6","article-title":"Clinical characteristics and prognosis of serous body cavity effusions in patients with sepsis: a retrospective observational study.","volume":"18","author":"Xing","year":"2018","journal-title":"BMC Anesthesiol"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"154763","DOI":"10.1016\/j.cyto.2019.154763","article-title":"TNF-\u03b1\u2212 308 G\/A variant and susceptibility to chronic obstructive pulmonary disease: a systematic review and meta-analysis.","volume":"123","author":"Asl","year":"2019","journal-title":"Cytokine"},{"key":"R27-20250504","first-page":"1346","article-title":"Levosimendan in the treatment of patients with severe septic cardiomyopathy.","volume":"13","author":"Tsolaki","year":"2023","journal-title":"Life (Basel)"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"18509","DOI":"10.1002\/jcb.29173","article-title":"Dexmedetomidine alleviates lipopolysaccharide-induced acute kidney injury by inhibiting the NLRP3 inflammasome activation via regulating the TLR4\/NOX4\/NF-\u03baB pathway.","volume":"120","author":"Yao","year":"2019","journal-title":"J Cell Biochem"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.neulet.2017.04.011","article-title":"Dexmedetomidine confers neuroprotection against transient global cerebral ischemia\/reperfusion injury in rats by inhibiting inflammation through inactivation of the TLR-4\/NF-\u03baB pathway.","volume":"649","author":"Kim","year":"2017","journal-title":"Neurosci Lett"},{"key":"R30-20250504","first-page":"675","article-title":"Effect of dexmedetomidine sedation on inflammatory factors in patients with mechanical ventilation sepsis.","volume":"16","author":"Wu","year":"2018","journal-title":"Chin J Gen Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040257","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:55:25Z","timestamp":1746320125000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,25]]},"references-count":30,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000040257","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,25]]}}}